Interim recommendations for use of the Valneva VLA2001 vaccine against COVID-19

Overview

These WHO interim recommendations for use of the Valneva VLA2001 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) on its 11 August 2022 extraordinary meeting and the evidence summary included in the background document and annexes referenced below.

For translations of this document in other languages, click here (forthcoming).